You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 11, November 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cefuroxime Therapy for Bacteremic Soft-Tissue Infections in Children

William J. Barson, MD; Marcia A. Miller, RN; Mario J. Marcon, PhD; Marilyn M. Hribar, MT, SM(ASCP); Michael T. Brady, MD; David L. Pacini, MD; Dwight A. Powell, MD

Am J Dis Child. 1985;139(11):1141-1144.


Abstract

• Although it is used extensively in Europe, there is a limited amount of published data concerning pediatric clinical experience with cefuroxime in the United States. Thirty-six children, ranging from 3.5 to 57 months of age, received intravenous cefuroxime (75 mg/kg/day in three divided doses) for soft-tissue infections of the face or epiglottis. infections treated included preseptal (19 patients) and buccal (13 patients) cellulitis and epiglottitis (four patients). Blood cultures were positive in 22 patients, yielding Haemophilus influenzae type b in 17 (four were βlactamase—positive), Streptococcus pneumoniae in four; and βlactamase—positive, nontypable H influenzae in one. An additional five patients with buccal cellulitis had negative blood cultures but H influenzae type b antigenuria. A satisfactory clinical response was noted in all patients, and repeated blood cultures performed in initially bacteremic patients were sterile. Cefuroxime therapy was well tolerated, and abnormal laboratory results were infrequent, except for absolute granulocytopenia (granulocytes, 1,500/cu mm), which occurred in six patients but could not be ascribed to a drug effect because of the uncontrolled design of our study. Treatment with cefuroxime appears to be a safe and effective therapy for pediatric soft-tissue infections due to H influenzae and S pneumoniae.

(AJDC 1985;139:1141-1144)



Author Affiliations

From the Section of Infectious Diseases, Department of Pediatrics, The Ohio State University College of Medicine and Children's Hospital, Columbus (Drs Barson, Brady, Pacini, and Powell and Ms Miller), and the Section of Microbiology, Department of Laboratory Medicine, Children's Hospital, and Department of Pathology, The Ohio State University College of Medicine (Dr Marcon and Ms Hribar).


Footnotes

Reprint requests to the Section of Infectious Diseases, Children's Hospital, 700 Children's Dr, Columbus, OH 43205 (Dr Barson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inpatient preseptal cellulitis: experience from a tertiary eye care centre
Chaudhry et al.
Br J Ophthalmol 2008;92:1337-1341.
ABSTRACT | FULL TEXT  

Onset of Hemophilus influenzae Type-b Meningitis During Cefaclor Therapy for Preseptal Cellulitis
Brady et al.
CLIN PEDIATR 1987;26:132-134.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.